Spandidos Publications style
Kim H, Kim E, Yang S, Jeong E, Park C, Kim S, Youn M, So H and Park R: Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction. Int J Oncol 28: 1401-1408, 2006.
APA
Kim, H., Kim, E., Yang, S., Jeong, E., Park, C., Kim, S. ... Park, R. (2006). Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction. International Journal of Oncology, 28, 1401-1408. https://doi.org/10.3892/ijo.28.6.1401
MLA
Kim, H., Kim, E., Yang, S., Jeong, E., Park, C., Kim, S., Youn, M., So, H., Park, R."Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction". International Journal of Oncology 28.6 (2006): 1401-1408.
Chicago
Kim, H., Kim, E., Yang, S., Jeong, E., Park, C., Kim, S., Youn, M., So, H., Park, R."Combination treatment with arsenic trioxide and sulindac augments their apoptotic potential in lung cancer cells through activation of caspase cascade and mitochondrial dysfunction". International Journal of Oncology 28, no. 6 (2006): 1401-1408. https://doi.org/10.3892/ijo.28.6.1401
